Stock Events

Stock Events

Keros Therapeutics (KROS) Q4 2024 Earnings

6NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-1.41

-1.34

-1.28

-1.21

Details

Expected EPS

-1.278663

Actual EPS

-1.41

Surprise EPS

-0.13

Surprise Percent

+10.27%

Description

Keros Therapeutics (KROS) has reported earnings of -1.41 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.